Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-09
2006-05-09
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S247000, C514S256000, C514S344000, C514S349000, C514S351000, C514S363000, C514S374000, C514S378000, C514S396000, C544S182000, C544S238000, C544S332000, C544S335000, C544S329000, C546S329000, C548S136000, C548S138000, C548S146000, C548S184000, C548S206000, C548S214000, C548S240000, C548S245000, C548S300100, C548S326500
Reexamination Certificate
active
07041670
ABSTRACT:
The present invention relates to novel florfenicol compounds having the chemical structure:wherein the compounds are useful for the treatment and/or prevention of bacterial infections in a broad range of patients such as, without limitation, birds, fish, shellfish and mammals.
REFERENCES:
patent: 3183265 (1965-05-01), von Strandtmann et al.
patent: 4235892 (1980-11-01), Nagabhushan
patent: 4361557 (1982-11-01), Nagabhushan
patent: 4582918 (1986-04-01), Nagabhushan et al.
patent: 4743700 (1988-05-01), Jommi et al.
patent: 4876352 (1989-10-01), Schumacher et al.
patent: 4918095 (1990-04-01), Della Bella et al.
patent: 4973750 (1990-11-01), Nagabhushan et al.
patent: 5082863 (1992-01-01), Apelian et al.
patent: 5105009 (1992-04-01), Jommi et al.
patent: 5153328 (1992-10-01), Jommi et al.
patent: 5243056 (1993-09-01), Jommi et al.
patent: 5332835 (1994-07-01), Jommi et al.
patent: 5352832 (1994-10-01), Wu et al.
patent: 5382673 (1995-01-01), Clark et al.
patent: 5567844 (1996-10-01), Jommi et al.
patent: 5621111 (1997-04-01), Lui et al.
patent: 5663361 (1997-09-01), Towson et al.
patent: 5789599 (1998-08-01), Davis et al.
patent: 5908937 (1999-06-01), Jommi et al.
patent: 638 755 (1964-04-01), None
patent: 669 982 (1966-03-01), None
patent: 0 014 437 (1983-02-01), None
patent: 4 604 (1966-11-01), None
Snyder et al., J. Med. Liban 48(4): 208-214, 2000.
Rogoz, Dissertationes Pharmaceuticae 16(2): 157-169, 1964. CA 62: 66234, 1965.
Supniewski et al., Bulletin de l'Academie Polonaise des Sciences, Serie des Sciences Biologigues 9, 231-234, 235-239, 1961. CA 56: 7514, 7507, 1962.
National Office of Animal Health, Antibiotics for Animals—An Overview, Briefing Document No. 6.
Hoflack, G., et al., “Efficacy of tilmicosin phosphate (Pulmotil premix) in feed for the treatment of a clinical outbreak ofActinobacillus pleuropneumoniaeinfection in growing-finishing pigs,”J Vet Med B Infect Dis Vet Public Health48(9):655-64 (Nov. 2001) (Abstract Only).
Compendium of Veterinary Products, Seventh Edition, pp. 1841-1842, 2043 (2003).
Hansch, Corwin, et al., “Structure-Activity Relationship of Chloramphenicols,”Journal of Medicinal Chemistry16:917-922 (1973).
Mitscher, Lester A., et al., “Circular Dichroism Studies of Aryl Diastereoisomers. 3. Cupra A Spectra of Chloramphenicol Derivatives,”Journal of Medicinal Chemistry16:98-101 (1973).
Nielsen, Peter E., et al., “Light Sensitive Chloramphenicol Analogues,”Acta Chemica Scandinavica BB29:662-66 (1975).
Von Strandtmann, Maximilian, et al., “Synthesis of p-Acyl Analogs of Chloramphenicol and their Antimicrobial Properties,”Journal of Medicinal Chemistry10:888-90 (1967).
Bolhofer, William, “The Preparation of Hydroxyphenylserines from Benzyloxybenzaldehydes and Glycine,”J. Am. Chem. Soc. 76:1322-26 (1954).
Bolton, Lance F., et al., “Detection of Multidrug-ResistantSalmonella entericaSerotypetyphimuriumDT104 Based on a Gene Which Confers Cross-Resistance to Florfenicol and Chloramphenicol,”Journal of Clinical Microbiology37:1348-1351 (1999).
Cloeckaert, Axel, et al., “Nonenzymatic Chloramphenicol Resistance Mediated by IncC Plasmid R55 Is Encodd by a floR Gene Variant,”Antimicrobial Agents and Chemotherapy45:2381-82 (2001).
Evans, David D., et al., “Analogues of Chloramphnicol. Part III*,”J. Chem. Soc. 1687-90 (1954).
Grehn, Leif, et al., “A Simple Method for tert-Butoxycarbonylation of Amides,”Acta Chemica Scandinavica B40:745-750 (1986).
Herbert, Richard B., et al., “Preparation of (2R,3S)-β-hydroxy-α-amino acids by use of a novelStreptomycesaldolase as a resolving agent for racemic material”Can. J. chem.72:114-17 (1994).
Ishizuka, Tadao, et al., “Mild and Selective Ring-Cleavage of Cyclic Carbamates to Amino Alcohols,”Tetrahedron Letters28:4185-88 (1987).
Jommi, Giancarlo, et al., “2-Oxazolidinones as Regioselective Protection of β-Amino Alcohols in the Synthesis of 2-Amino-1-Aryl-3-Fluoro-1-Proponals,”Gazz. Chim. Ital. 116:485-89 (1986).
Jommi, Giancarlo, et al., “Mild Recovery of β-Amino Alcohols from the Corresponding 2-Oxazolidinones(*)”Gazzetta Chimica Italiana118:75-76 (1988).
Keyes, Kathleen, et al., “Detection of Florfenicol Resistance Genes inEscherichia coliIsolated from Sick Chickens,”Antimicrobial Agents and Chemotherapy44:421-24 (2000).
Kim, Eun-heui, et al., “Sequence Analysis of the Florfenicol Resistance Gene Encoded in the Transferable R-Plasmid of a Fish Pathogen,Pasteurella piscicida,” Microbiol. Immunol. 40:665-69 (1996).
Lal, Gauri S., et al., “Bis(2-methoxyethyl)aminosulfur Trifluoride: A New Broad-Spectrum Deoxofluorinating Agent with Enhanced Thermal Stability,”J. Org. Chem. 64:7048-54 (1999).
Lam, Patrick Y.S., et al., “New Aryl/Heteroaryl C-N Bond Cross-coupling Reactions via Arylboronic Acid/Cupric Acetate Arylation,”Tetrahedron Letters39:2941-44 (1998).
Lam, Patrick Y.S., et al., “Copper Promoted Aryl/Saturated Heterocyclic C-N Bond Cross-Coupling with Arylboronic Acid and Arylstannane,”Synlett5:674-76 (2000).
Lam, Patrick Y.S., et al., “Copper-catalyzed general C-N and C-O bond cross-coupling with arylboronic acid”Tetrahedron Letters42:3415-18 (2001).
Morris, et al., “Analogues of Chloramphenicol. Part I,”J. Chem. Soc.1680-86 (1954).
Pines, Seemon, et al. “Substituent Effects in the Reaction of N-Benzoyl-β-arylserinates with Thionyl Chloride,”J. Org. Chem.37:292-97(1972).
Rebstock, M.C., et al., “Chloramphenicol (Chloromycetin). IV. Chemical Studies,”J. Am. Chem. Soc. 71:2458-62 (1949).
Shaw, W.V., et al., “Chloramphenicol Resistance by Enzymatic Acetylation: Comparative Aspects,”Antimicrobial Agents and Chemotherapy257-63 (1968).
Von Strandtmann, M., et al., “Synthesis of p-Acyl Analogs of Chloramphenicol and Their Antimicrobial Properties,”J. Am. Chem. 10:888-90 (1967).
Yu, Kuo-Long, et al., “Retinoic Acid Receptor β, γ-Selective Ligands: Synthesis and Biological Activity of 6-Substituted 2-Naphthoic Acid Retinoids,”J. Med. Chem. 39:2411-21 (1996).
Boojamra Constantine G.
Chong Lee S.
Glinka Tomasz W.
Hecker Scott J.
Shuster Dale E.
Balasubramanian Venkataraman
Schering-Plough Animal Health Corporation
LandOfFree
Florfenicol-type antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Florfenicol-type antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Florfenicol-type antibiotics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3598560